Creating Small Molecule Drugs for Viral Infections and Liver Diseases

Learn More
  • Research

    At Enanta, our research is focused on multiple therapeutic areas where there in a high unmet need.

    Learn More.

  • Careers

    Join the Enanta Team

    Learn More.

  • News

    Enanta Pharmaceuticals to Present New Preclinical Data on EDP-305, an FXR Agonist for NASH and PBC,

Enanta’s diversified portfolio is focused primarily on unmet medical needs such as non-alcoholic steatohepatitis (NASH)/ primary biliary cholangitis (PBC), respiratory syncytial virus (RSV) and hepatitis B virus (HBV)